Effect of dexamethasone on lipoprotein lipase activity of fetal rat lung.
Dexamethasone was administered by continuous subcutaneous infusions (16 microgram/kg/h) to pregnant rats from day 16 of gestation. Administration of the hormone markedly affected maternal and fetal weight gain, fetal lung:body weight ratio and lipoprotein lipase activity of the lung. Cumulative maternal weight gain from days 15-21 of gestation was 80 +/- 4.0 g in control and 30 +/- 10 g in dexamethasone-treated rats. Fetal weight at 22 days of gestation and 1 day after birth was 5.5 +/- 0.39 and 8.6 +/- 0.30 in control and 4.65 +/- 0.26 and 5.9 +/- 0.34 in dexamethasone-treated rats. The ratio of lung weight to body weight was lower throughout the last 5 days of gestation in dexamethasone-treated than in control rats. Dexamethasone administration led to a 2- to 3-fold increase in lipoprotein lipase activity levels in fetal rat lung at 19 and 20 days' gestation and prevented the decline in enzyme activity shortly before birth. Stimulation of fetal lung lipoprotein lipase activity suggests that increased uptake of triglyceride-fatty acids by the lung could be a contributory factor to corticosteroid-enhanced surfactant synthesis.
D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D001835:Body Weight; D003907:Dexamethasone / Q000494:pharmacology*; D002149:Energy Intake; D005260:Female; D005333:Fetus / Q000502:physiology; D005865:Gestational Age; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008168:Lung / Q000196:embryology / Q000201:enzymology*; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains
D003907:Dexamethasone; D008071:Lipoprotein Lipase